Protection from experimental autoimmune
โ
Ferdinando Nicoletti; Roberto di Marcou; Wilma Barcelliniu; Gaetano Magro; Hans
๐
Article
๐
1994
๐
John Wiley and Sons
๐
English
โ 564 KB
## and Research Laboratories of the Behringwerkee, Marburg We have evaluated the effects of a treatment with soluble interleukin-1 receptor (sIL-1R) in the accelerated model of autoimmune diabetes induced by cyclophosphamide (CY) in the non-obese diabetic (NOD) mouse. Prior to the CY challenge (35